Butyrophilin subfamily 3 member A1–Butyrophilin subfamily 2 member A1 complex (BTN3A1–BTN2A1 complex)

The Butyrophilin subfamily 3 member A1–Butyrophilin subfamily 2 member A1 complex is a cell-surface immunoregulatory receptor complex essential for the detection of small phosphorylated antigenic molecules (phosphoantigens) produced by microbes or dysregulated host metabolism[1][3][4]. Upon intracellular binding of phosphoantigens (such as HMBPP, IPP, or the metabolites induced by zoledronate) to BTN3A1, a conformational change enables association with BTN2A1, forming a composite interface on the cytoplasmic side of the membrane that drives activation of Vγ9Vδ2 T cells—a key subset of γδ T cells important for immune surveillance against tumors and infections. This "inside-out" signaling is unique in that it links intracellular metabolic cues to extracellular presentation for T cell recognition, representing a major pathway for unconventional T cell activation[1][2][3][4][5]. Recent structural and biochemical studies have enabled the rational design of small molecules and antibodies to modulate this pathway, supporting the BTN3A1-BTN2A1 complex as an emerging immunotherapeutic target.

Other names

Butyrophilin 3A1–Butyrophilin 2A1 complexBTN3A1/BTN2A1 complexButyrophilin-3A1 and -2A1 complexPhosphoantigen-sensing butyrophilin complex

Small-molecule phosphoantigens (e.g., HMBPP, IPP, DMAPP, zoledronate-induced metabolites) act as "molecular glues," binding the intracellular B30.2 domain of BTN3A1 and promoting heteromeric association with BTN2A1, leading to conformational changes that activate Vγ9Vδ2 T cells[1][3][4].